نتایج جستجو برای: hbs titer
تعداد نتایج: 16210 فیلتر نتایج به سال:
Introduction & Objective: Hepatitis B is a recent century disease. Estimated that exist more than 350 million persons suffering from this disease in worldwide. Also hepatitis B is a serious health problem and is among the 10 leading causes of death in Iran. This study aims is to identify the antibody titer hepatitis B in Hamedan's nursing and midwifery students as an alternative preventive meas...
BACKGROUND AND AIMS The duration of the protection of hepatitis B vaccination for infants and the necessity of a booster dose administration is unknown. The aim of the present study was to evaluate the persistence of seroprotection after hepatitis B virus (HBV) vaccination in order to determine the necessity of a single booster dose in 5- to 7-year-old children. METHODS This clinical trial st...
BACKGROUND Malnutrition is the most common cause of immune deficiency. It results in reduced secretion of T-cells and B-cell-stimulating factors leading to declining of special immunoglobulins. On the other hand, hepatitis B, as a major world health problem, can be prevented effectively by vaccination. Three doses of hepatitis B virus (HBV) vaccine induce protective levels of anti-hepatitis B s...
The human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized, open-label study, we compared the immunogenicity of the hepatitis B vaccine administered alone (HepB group) or with the HPV-16/18 AS04-adjuvanted...
Giriş ve amaç: Bu çalışmanın amacı, kronik bel ağrısı olan hastalarda Huzursuz Bacak Sendromu’nun (HBS) risk faktörlerini denge üzerine etkisini incelemektir.
 Gereç yöntem: Pamukkale Üniversitesi Hastanelerine daha önce şikayetiyle başvurmuş, dahil edilme kriterlerine uyan 98 olgu dâhil edilmiştir. olgulardan HBS (HBS+) 66 çalışma grubuna, olmayan (HBS-) 32 ise kontrol grubuna alınmıştır....
Background & Aim: Hepatitis B vaccine is in national vaccination programs. In healthy individuals the immune response is complete d by three-dose injections in 95% of cases and remains complete with time. However, in patients with chronic transfusion this immune response may be incomplete . In such patients, it is advised to check HBs antibody periodically, and use booster dose in cases with ...
Background and Aim: Hepatitis B virus is the cause of acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Its prevalence has been reported to be 0.1%-0.5% and 1.6%-6.5% in the United States and Iran respectively. At present, the only sure preventive measure is vaccination but it does not create absolute (100%) immunity. Antibody production is between 79% to 90%, which occurs t...
The prevention of hepatitis B by vaccination is one of the most efficient tools to avoid the transmission of the virus. This study evaluated the immunogenicity of the national vaccine Butang in children born in Campo Mourão City, state of Paraná, Brazil, aged 7 to 12 months, by determining the anti-HBsAg antibodies levels after completion of the National Immunization Program Protocol for hepati...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید